Regulation & Compliance

A new 'authority' claims to offer specialized fintech licenses, but investigation reveals a critical warning for the booming digital finance industry.

A new joint venture merges Arna's innovation with Slate Run's market muscle, launching a key diagnostic and targeting high-value specialty medicines.

A key workshop aims to bridge the gap between FDA policy and patient needs, seeking to streamline therapy development for millions with rare diseases.

NEAR AI integrates USDC with Confidential Intents, enabling AI agents to transact privately and paving the way for a new era of autonomous machine commerce.

A new report reveals a startling trend: fewer recall events are leading to a massive 27% surge in recalled units, signaling larger, more dangerous defects.

Infoblox and GoDaddy are championing open standards using DNS to create a vital identity and verification layer for the coming wave of AI agents.

With the hire of veteran Sarah Schmitz, Balefire Wealth signals a major strategic expansion into the complex world of corporate retirement consulting.

The new platform introduces an AI 'agent' to unify data, automate execution, and transform sales coaching, moving beyond reactive reports to real-time action.

Viamedia.ai's Geo-Graph™ now uses Uber's H3 grid, promising a new privacy-first standard for ad targeting without cookies or mobile identifiers.

A new wave of MedTech innovators is ditching fragmented systems for unified, AI-driven platforms, accelerating life-saving device development. Here's why.

Former Trump official Peter O'Rourke joins AI defense firm Quantum Cyber, a move signaling a major push for government contracts in autonomous warfare.

Paiday and NumaTrack merge to form Nooma, an AI-native platform aiming to solve the deep-seated inefficiencies plaguing Canadian accounting firms.

Many top professionals are diagnosed with ADHD, but a new analysis claims the real cause is childhood conditioning, not neurology. Is the cure a misstep?

Dr. Amie Hornaman's bestseller, The Thyroid Fix, confronts medical gaslighting, empowering women to look beyond 'normal' lab results for answers.

A federal jury exonerated hedge fund Armistice Capital of all fraud claims related to Vaxart's COVID-era stock surge, a major trial loss for investors.

Fresh off its IPO, Agomab Therapeutics is presenting key data for its new IPF drug, AGMB-447, while courting investors on a multi-conference tour.

On May 18, competitors like Ulta and CVS join forces for National Sun Responsibly Day, an urgent call to make daily sun protection a life-saving habit.

Backed by SEI's billions, Stratos's acquisition spree isn't just about growth; it's pioneering a new partnership model for independent financial advisors.

With a new VP and expanded partnerships, KIBO Commerce is capitalizing on the region's shift away from legacy tech to its flexible, composable solutions.

Israel's top bank reports NIS 2.1B profit, showcasing economic resilience amid conflict and regulatory pressure while rewarding shareholders with dividends.